Trump administration eases access to unproven peptides favored by RFK Jr.
The Department of Health and Human Services issued a policy directing the FDA not to enforce rules against pharmacies that compound certain injectable peptides, after FDA scientific staff opposed the move.
Compiled by Stancr from 3 articles by 3 outletsPublished Updated 0 comments
Who covered it
3 articles from rated outlets · 0 wire/unrated
FL 1L 1R 1
Conspiracy left 0
Far left 1
Left 1
Right 1
Far right 0
Conspiracy right 0
Wire / unrated 0
Where readers stand
Readers: no picks yet
What we know
The Department of Health and Human Services posted a draft policy on Wednesday that directs the FDA not to take action against specialty pharmacies selling a half-dozen wellness peptides, including BPC-157, TB-500 and KPV.
Most FDA scientific staff opposed the effort and had limited input in drafting the policy, according to six people familiar with its development who spoke to the Associated Press on condition of anonymity.
FDA staff warned the policy could undermine the agency's mission of keeping unproven or unsafe health products off the US market.
The peptides are promoted for uses such as building muscle, healing injuries and boosting energy, and under normal FDA rules would be considered illegal drugs because they have not gone through the agency's review process for safety and effectiveness.
Health Secretary Robert F. Kennedy Jr. has called himself a 'big fan' of peptides and described using BPC-157 for a muscle injury; an HHS spokesperson did not immediately respond to a request for comment.
Highlights scientists rebelling over peptide access plan
Raw Story: Scientists rebel over RFK Jr.'s 'unproven' health product access plan: report
No readers have picked a side yet. Shares show once 10 have.
Raw Story frames the policy as an unproven health product access plan that faced overwhelming opposition from FDA scientists, prompting the department to change tactics.
Progressive and socialist outlets such as Common Dreams, Democracy Now and Truthout. Usually focuses on corporate power, workers, inequality and anti-war positions.
Reports FDA scientists opposed easing peptide access
The Guardian US (Politics): FDA scientists opposed Trump administration’s move to ease peptide access
No readers have picked a side yet. Shares show once 10 have.
The Guardian US emphasizes that most FDA scientific staff opposed the effort to loosen rules on unproven peptide drugs favored by RFK Jr. and had limited input in drafting the policy.
Mainstream liberal outlets such as CNN, MSNBC, NPR and The Washington Post. Usually focuses on who is affected, climate, public institutions and criticism of the Trump administration.
New York Post (Politics): Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition
No readers have picked a side yet. Shares show once 10 have.
The New York Post reports that the Trump administration acted to ease access to unproven peptides favored by RFK Jr. despite FDA opposition, noting the policy will take comments for two weeks before finalizing.
Mainstream conservative outlets such as Fox News, the Washington Examiner and the New York Post. Usually focuses on costs, security, government overreach and Democratic policy.
The opposite side says
Left: Reports FDA scientists opposed easing peptide access
Where readers stand
Consp. LFar leftLeftRightFar rightConsp. R
0 readers picked a side. They sit near the centre.
0 visitors without an account picked a side. Counted separately, not in the readers above.
